Antiviral activity of peptide inhibitors derived from the protein E stem against Japanese encephalitis and Zika viruses

Antiviral Research

Volumn 141, Issue , 2017, Pages 140-149

  Chen, Liman ^a,b   Liu, Yang ^a   Wang, Shaobo ^a,b   Sun, Jianhong ^a,b   Wang, Peilin ^a,b   Xin, Qilin ^a,b   Zhang, Leike ^a,b   Xiao, Gengfu ^a,b   Wang, Wei ^a,b  

^a WUHAN INSTITUTE OF VIROLOGY   (China)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

Author keywords

Glycoprotein; Japanese encephalitis virus; Peptide inhibitors; Stem; Zika virus

Indexed keywords

GLYCOPROTEIN E; PEPTIDE; PEPTIDE P5; SCRAMBLED PEPTIDE P5; UNCLASSIFIED DRUG; ANTIVIRUS AGENT; PEPTIDE FRAGMENT; VIRUS FUSION PROTEIN;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIVIRAL ACTIVITY; ARTICLE; BRAIN; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IC50; IN VITRO STUDY; IN VIVO STUDY; INFECTION PREVENTION; JAPANESE ENCEPHALITIS; JAPANESE ENCEPHALITIS VIRUS; MALE; MOUSE; NONHUMAN; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; TESTIS; VIRUS LOAD; ZIKA FEVER; ZIKA VIRUS; ANIMAL; CELL LINE; CHEMISTRY; DRUG EFFECTS; PATHOLOGY; VIROLOGY; VIRUS REPLICATION;

ANIMALS; ANTIVIRAL AGENTS; BRAIN; CELL LINE; ENCEPHALITIS VIRUS, JAPANESE; ENCEPHALITIS, JAPANESE; INHIBITORY CONCENTRATION 50; MALE; MICE; PEPTIDE FRAGMENTS; TESTIS; VIRAL FUSION PROTEINS; VIRAL LOAD; VIRUS REPLICATION; ZIKA VIRUS;

EID: 85014492229     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2017.02.009     Document Type: Article

References (61)

1. Altmeyer, R., Virus attachment and entry offer numerous targets for antiviral therapy. Curr. Pharm. Des. 10 (2004), 3701–3712.
2. Arzuza-Ortega, L., Polo, A., Perez-Tatis, G., Lopez-Garcia, H., Parra, E., Pardo-Herrera, L.C., Rico-Turca, A.M., Villamil-Gomez, W., Rodriguez-Morales, A.J., Fatal sickle cell disease and Zika virus infection in girl from Colombia. Emerg. Infect. Dis. 22 (2016), 925–927.
3. Ashraf, U., Zhu, B., Ye, J., Wan, S., Nie, Y., Chen, Z., Cui, M., Wang, C., Duan, X., Zhang, H., Chen, H., Cao, S., MicroRNA-19b-3p modulates Japanese encephalitis virus-mediated inflammation via targeting RNF11. J. Virol. 90 (2016), 4780–4795.
4. Banks, W.A., Kastin, A.J., Peptides and the blood-brain barrier: lipophilicity as a predictor of permeability. Brain Res. Bull. 15 (1985), 287–292.
5. Brasil, P., Pereira, J.P. Jr., Raja Gabaglia, C., Damasceno, L., Wakimoto, M., Ribeiro Nogueira, R.M., Carvalho de Sequeira, P., Machado Siqueira, A., Abreu de Carvalho, L.M., Cotrim da Cunha, D., Calvet, G.A., Neves, E.S., Moreira, M.E., Rodrigues Baiao, A.E., Nassar de Carvalho, P.R., Janzen, C., Valderramos, S.G., Cherry, J.D., Bispo de Filippis, A.M., Nielsen-Saines, K., Zika Virus Infection in Pregnant Women in Rio de Janeiro - preliminary report. N. Engl. J. Med. 375 (2016), 2321–2334.
6. Brecher, M., Zhang, J., Li, H., The flavivirus protease as a target for drug discovery. Virol. Sin. 28 (2013), 326–336.
7. de Araujo, T.V., Rodrigues, L.C., de Alencar Ximenes, R.A., de Barros Miranda-Filho, D., Montarroyos, U.R., de Melo, A.P., Valongueiro, S., de Albuquerque, M.F., Souza, W.V., Braga, C., Filho, S.P., Cordeiro, M.T., Vazquez, E., Di Cavalcanti Souza Cruz, D., Henriques, C.M., Bezerra, L.C., da Silva Castanha, P.M., Dhalia, R., Marques-Junior, E.T., Martelli, C.M., investigators from the Microcephaly Epidemic Research G, Brazilian Ministry of H, Pan American Health O, Instituto de Medicina Integral Professor Fernando F., State Health Department of P, Association between Zika Virus Infection and Microcephaly in Brazil, January to May, 2016: Preliminary Report of a Case-control Study., 2016, The Lancet Infectious diseases.
8. Dyer, O., Outbreak of Zika in Singapore sparks warnings in neighbouring countries. Bmj, 354, 2016, i4740.
9. Erlanger, T.E., Weiss, S., Keiser, J., Utzinger, J., Wiedenmayer, K., Past, present, and future of Japanese encephalitis. Emerg. Infect. Dis. 15 (2009), 1–7.
10. Fan, J., Liu, Y., Xie, X., Zhang, B., Yuan, Z., Inhibition of Japanese encephalitis virus infection by flavivirus recombinant E protein domain III. Virol. Sin. 28 (2013), 152–160.
11. Fauci, A.S., Morens, D.M., Zika virus in the Americas–yet another arbovirus threat. N. Engl. J. Med. 374 (2016), 601–604.
12. Govero, J., Esakky, P., Scheaffer, S.M., Fernandez, E., Drury, A., Platt, D.J., Gorman, M.J., Richner, J.M., Caine, E.A., Salazar, V., Moley, K.H., Diamond, M.S., Zika virus infection damages the testes in mice. Nature 540 (2016), 438–442.
13. Heinz, F.X., Allison, S.L., Structures and mechanisms in flavivirus fusion. Adv. Virus Res. 55 (2000), 231–269.
14. Hrobowski, Y.M., Garry, R.F., Michael, S.F., Peptide inhibitors of dengue virus and West Nile virus infectivity. Virol. J., 2, 2005, 49.
15. Jin, R., Zhu, W., Cao, S., Chen, R., Jin, H., Liu, Y., Wang, S., Wang, W., Xiao, G., Japanese encephalitis virus activates autophagy as a viral immune evasion strategy. PLoS One, 8, 2013, e52909.
16. Julander, J.G., Siddharthan, V., Evans, J., Taylor, R., Tolbert, K., Apuli, C., Stewart, J., Collins, P., Gebre, M., Neilson, S., Van Wettere, A., Lee, Y.M., Sheridan, W.P., Morrey, J.D., Babu, Y.S., Efficacy of the broad-spectrum antiviral compound BCX4430 against Zika virus in cell culture and in a mouse model. Antivir. Res. 137 (2017), 14–22.
17. Kalia, M., Khasa, R., Sharma, M., Nain, M., Vrati, S., Japanese encephalitis virus infects neuronal cells through a clathrin-independent endocytic mechanism. J. Virol. 87 (2013), 148–162.
18. Kielian, M., Class II virus membrane fusion proteins. Virology 344 (2006), 38–47.
19. Kleber de Oliveira, W., Cortez-Escalante, J., De Oliveira, W.T., do Carmo, G.M., Henriques, C.M., Coelho, G.E., Araujo de Franca, G.V., Increase in reported prevalence of microcephaly in infants born to women living in areas with confirmed Zika virus transmission during the first trimester of pregnancy - Brazil, 2015. MMWR Morb. Mortal. Wkly. Rep. 65 (2016), 242–247.
20. Koehler, J.W., Smith, J.M., Ripoll, D.R., Spik, K.W., Taylor, S.L., Badger, C.V., Grant, R.J., Ogg, M.M., Wallqvist, A., Guttieri, M.C., Garry, R.F., Schmaljohn, C.S., A fusion-inhibiting peptide against Rift Valley fever virus inhibits multiple, diverse viruses. PLoS Negl. Trop. Dis., 7, 2013, e2430.
21. Kostyuchenko, V.A., Lim, E.X., Zhang, S., Fibriansah, G., Ng, T.S., Ooi, J.S., Shi, J., Lok, S.M., Structure of the thermally stable Zika virus. Nature 533 (2016), 425–428.
22. Kuhn, R.J., Zhang, W., Rossmann, M.G., Pletnev, S.V., Corver, J., Lenches, E., Jones, C.T., Mukhopadhyay, S., Chipman, P.R., Strauss, E.G., Baker, T.S., Strauss, J.H., Structure of dengue virus: implications for flavivirus organization, maturation, and fusion. Cell 108 (2002), 717–725.
23. Lazear, H.M., Govero, J., Smith, A.M., Platt, D.J., Fernandez, E., Miner, J.J., Diamond, M.S., A mouse model of Zika virus pathogenesis. Cell Host Microbe 19 (2016), 720–730.
24. Lednicky, J., Beau De Rochars, V.M., El Badry, M., Loeb, J., Telisma, T., Chavannes, S., Anilis, G., Cella, E., Ciccozzi, M., Rashid, M., Okech, B., Salemi, M., Morris, J.G. Jr., Zika virus outbreak in Haiti in 2014: molecular and clinical data. PLoS Negl. Trop. Dis., 10, 2016, e0004687.
25. Lee, C.J., Lin, H.R., Liao, C.L., Lin, Y.L., Cholesterol effectively blocks entry of flavivirus. J. Virol. 82 (2008), 6470–6480.
26. Liao, M., Kielian, M., Domain III from class II fusion proteins functions as a dominant-negative inhibitor of virus membrane fusion. J. Cell Biol. 171 (2005), 111–120.
27. Liao, M., Sanchez-San Martin, C., Zheng, A., Kielian, M., In vitro reconstitution reveals key intermediate states of trimer formation by the dengue virus membrane fusion protein. J. Virol. 84 (2010), 5730–5740.
28. Liu, H., Liu, Y., Wang, S., Zhang, Y., Zu, X., Zhou, Z., Zhang, B., Xiao, G., Structure-based mutational analysis of several sites in the E protein: implications for understanding the entry mechanism of Japanese encephalitis virus. J. Virol. 89 (2015), 5668–5686.
29. Liu, J., Liu, Y., Nie, K., Du, S., Qiu, J., Pang, X., Wang, P., Cheng, G., Flavivirus NS1 protein in infected host sera enhances viral acquisition by mosquitoes. Nat. Microbiol., 1, 2016, 16087.
30. Liu, S., Xiao, G., Chen, Y., He, Y., Niu, J., Escalante, C.R., Xiong, H., Farmar, J., Debnath, A.K., Tien, P., Jiang, S., Interaction between heptad repeat 1 and 2 regions in spike protein of SARS-associated coronavirus: implications for virus fusogenic mechanism and identification of fusion inhibitors. Lancet 363 (2004), 938–947.
31. Ma, W., Li, S., Ma, S., Jia, L., Zhang, F., Zhang, Y., Zhang, J., Wong, G., Zhang, S., Lu, X., Liu, M., Yan, J., Li, W., Qin, C., Han, D., Qin, C., Wang, N., Li, X., Gao, G.F., Zika virus causes testis damage and leads to male infertility in mice. Cell 167 (2016), 1511–1524.
32. Mackenzie, J.S., Gubler, D.J., Petersen, L.R., Emerging flaviviruses: the spread and resurgence of Japanese encephalitis, West Nile and dengue viruses. Nat. Med. 10 (2004), S98–S109.
33. Medigeshi, G.R., Hirsch, A.J., Streblow, D.N., Nikolich-Zugich, J., Nelson, J.A., West Nile virus entry requires cholesterol-rich membrane microdomains and is independent of alphavbeta3 integrin. J. Virol. 82 (2008), 5212–5219.
34. Misra, U.K., Kalita, J., Overview: Japanese encephalitis. Prog. Neurobiol. 91 (2010), 108–120.
35. Mlakar, J., Korva, M., Tul, N., Popovic, M., Poljsak-Prijatelj, M., Mraz, J., Kolenc, M., Resman Rus, K., Vesnaver Vipotnik, T., Fabjan Vodusek, V., Vizjak, A., Pizem, J., Petrovec, M., Avsic Zupanc, T., Zika virus associated with microcephaly. N. Engl. J. Med. 374 (2016), 951–958.
36. Modis, Y., Ogata, S., Clements, D., Harrison, S.C., Structure of the dengue virus envelope protein after membrane fusion. Nature 427 (2004), 313–319.
37. Mukhopadhyay, S., Kim, B.S., Chipman, P.R., Rossmann, M.G., Kuhn, R.J., Structure of West Nile virus. Science, 302, 2003, 248.
38. Nawa, M., Machida, S., Takasaki, T., Kurane, I., Plaque formation by Japanese encephalitis virus bound to mosquito C6/36 cells after low pH exposure on the cell surface. Jpn. J. Infect. Dis. 60 (2007), 118–120.
39. Nawa, M., Takasaki, T., Yamada, K., Kurane, I., Akatsuka, T., Interference in Japanese encephalitis virus infection of Vero cells by a cationic amphiphilic drug, chlorpromazine. J. Gen. Virol. 84 (2003), 1737–1741.
40. Pangerl, K., Heinz, F.X., Stiasny, K., Mutational analysis of the zippering reaction during flavivirus membrane fusion. J. Virol. 85 (2011), 8495–8501.
41. Perera, R., Khaliq, M., Kuhn, R.J., Closing the door on flaviviruses: entry as a target for antiviral drug design. Antivir. Res. 80 (2008), 11–22.
42. Petersen, L.R., Jamieson, D.J., Powers, A.M., Honein, M.A., Zika virus. N. Engl. J. Med. 374 (2016), 1552–1563.
43. Pierson, T.C., Kielian, M., Flaviviruses: braking the entering. Curr. Opin. Virol. 3 (2013), 3–12.
44. Rasmussen, S.A., Jamieson, D.J., Honein, M.A., Petersen, L.R., Zika virus and birth defects–reviewing the evidence for causality. N. Engl. J. Med. 374 (2016), 1981–1987.
45. Rey, F.A., Heinz, F.X., Mandl, C., Kunz, C., Harrison, S.C., The envelope glycoprotein from tick-borne encephalitis virus at 2 A resolution. Nature 375 (1995), 291–298.
46. Robert, X., Gouet, P., Deciphering key features in protein structures with the new ENDscript server. Nucleic Acids Res. 42 (2014), W320–W324.
47. Schmidt, A.G., Yang, P.L., Harrison, S.C., Peptide inhibitors of dengue-virus entry target a late-stage fusion intermediate. PLoS Pathog., 6, 2010, e1000851.
48. Schmidt, A.G., Yang, P.L., Harrison, S.C., Peptide inhibitors of flavivirus entry derived from the E protein stem. J. Virol. 84 (2010), 12549–12554.
49. Sia, S.K., Carr, P.A., Cochran, A.G., Malashkevich, V.N., Kim, P.S., Short constrained peptides that inhibit HIV-1 entry. Proc. Natl. Acad. Sci. U. S. A. 99 (2002), 14664–14669.
50. Sirohi, D., Chen, Z., Sun, L., Klose, T., Pierson, T.C., Rossmann, M.G., Kuhn, R.J., The 3.8 A resolution cryo-EM structure of Zika virus. Science 352 (2016), 467–470.
51. Solomon, T., Flavivirus encephalitis. N. Engl. J. Med. 351 (2004), 370–378.
52. Unni, S.K., Ruzek, D., Chhatbar, C., Mishra, R., Johri, M.K., Singh, S.K., Japanese encephalitis virus: from genome to infectome. Microbes Infect. 13 (2011), 312–321.
53. Vaughn, D.W., Hoke, C.H. Jr., The epidemiology of Japanese encephalitis: prospects for prevention. Epidemiol. Rev. 14 (1992), 197–221.
54. Wang, S., Liu, H., Zu, X., Liu, Y., Chen, L., Zhu, X., Zhang, L., Zhou, Z., Xiao, G., Wang, W., The ubiquitin-proteasome system is essential for the productive entry of Japanese encephalitis virus. Virology 498 (2016), 116–127.
55. Weaver, S.C., Costa, F., Garcia-Blanco, M.A., Ko, A.I., Ribeiro, G.S., Saade, G., Shi, P.Y., Vasilakis, N., Zika virus: history, emergence, biology, and prospects for control. Antivir. Res. 130 (2016), 69–80.
56. Yang, Y., Ye, J., Yang, X., Jiang, R., Chen, H., Cao, S., Japanese encephalitis virus infection induces changes of mRNA profile of mouse spleen and brain. Virol. J., 8, 2011, 80.
57. Zhang, W., Chipman, P.R., Corver, J., Johnson, P.R., Zhang, Y., Mukhopadhyay, S., Baker, T.S., Strauss, J.H., Rossmann, M.G., Kuhn, R.J., Visualization of membrane protein domains by cryo-electron microscopy of dengue virus. Nat. Struct. Biol. 10 (2003), 907–912.
58. Zhang, Y., Zhang, W., Ogata, S., Clements, D., Strauss, J.H., Baker, T.S., Kuhn, R.J., Rossmann, M.G., Conformational changes of the flavivirus E glycoprotein. Structure 12 (2004), 1607–1618.
59. Zhu, Y.Z., Xu, Q.Q., Wu, D.G., Ren, H., Zhao, P., Lao, W.G., Wang, Y., Tao, Q.Y., Qian, X.J., Wei, Y.H., Cao, M.M., Qi, Z.T., Japanese encephalitis virus enters rat neuroblastoma cells via a pH-dependent, dynamin and caveola-mediated endocytosis pathway. J. Virol. 86 (2012), 13407–13422.
60. Zu, X., Liu, Y., Wang, S., Jin, R., Zhou, Z., Liu, H., Gong, R., Xiao, G., Wang, W., Peptide inhibitor of Japanese encephalitis virus infection targeting envelope protein domain III. Antivir. Res. 104 (2014), 7–14.
61. http://www.who.int/mediacentre/factsheets/fs386/en/.